Andreas Johannes Kandziora
Direktor/Vorstandsmitglied bei Helix Immuno-Oncology SA
Ursprung des Netzwerks ersten Grades von Andreas Johannes Kandziora
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andreas Johannes Kandziora
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ORLEN SPÓ?KA AKCYJNA | Oil Refining/Marketing | Chief Executive Officer | |
| HELIX BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
ORLEN Lietuva AB
 ORLEN Lietuva AB Oil Refining/MarketingEnergy Minerals ORLEN Lietuva AB refines, markets, and distributes petroleum products. Its activities include oil refining, pipeline and marine terminal operations, marketing, and logistics of refined products. The firm markets products in the Lithuanian, Latvian, and Estonian markets through Mazeikiu Nafta Trading House. The company was founded on March 28, 1995 and is headquartered in Mazeikiai, Lithuania. | Oil Refining/Marketing | Chief Executive Officer | |
| PKO BANK POLSKI S.A. | Major Banks | Director/Board Member | |
Bank Gospodarstwa Krajowego SA
 Bank Gospodarstwa Krajowego SA Finance/Rental/LeasingFinance Bank Gospodarstwa Krajowego SA provides state-owned bank supporting public finance activities. It also offers commercial banking and depository services and products, specializing in servicing and financing enterprises and local government entities. It also funds government projects, such as highway construction. The company was founded in 1924 and is headquartered in Warsaw, Poland. | Finance/Rental/Leasing | Chief Executive Officer | |
Sensium Technologies, Inc.
 Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Miscellaneous Commercial Services | President | |
| Queen's University | College/University | Doctorate Degree | |
| Cracow University of Economics | College/University | Undergraduate Degree | |
| National Health Fund | Director/Board Member | ||
| Social Insurance Institution | State Agency | Corporate Officer/Principal | |
| ROCKBRIDGE FUNDUSZ INWESTYCYJNY ZAMKNIETY BEZPIECZNA INWESTYCJA 2 | Investment Trusts/Mutual Funds | Director/Board Member | |
| PURE BIOLOGICS S.A. | Biotechnology | Director/Board Member |
Statistik
International
| Polen | 11 |
| Kanada | 4 |
| Litauen | 2 |
Sektoral
| Energy Minerals | 4 |
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 8 |
| Chief Executive Officer | 7 |
| Corporate Officer/Principal | 6 |
| President | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Andreas Johannes Kandziora
- Unternehmensverbindungen
